Continuing to challenge the current HIV treatment paradigm, data presented will investigate new and innovative treatment options for people living with HIV. ViiV Healthcare will be presenting over 20 abstracts during next week at the 23rd International AIDS Conference (AIDS 2020: Virtual), being held 6-10 July. Because of the COVID-19… Read More
The UK based AI start-up is offering all researchers free use of Galactic, its cloud-based web tool, to support biomedical research while lab access is restricted around the world. According to Biorelate, the cognitive computing platform behind Galactic can speed up the research process by collecting and curating… Read More
Start-up iLoF (Intelligent Lab on Fiber), uses artificial intelligence (AI) and biophotonics to detect neurogenerative biomarkers and optimise the clinical trial selection process for diseases such as Alzheimer’s. iLoF also won the EIT Health Wild Card competition in 2019 and has secured $1 million in investment from Microsoft’s… Read More
A novel machine learning model developed by researchers at Michigan State University suggests that mutations to the SARS-CoV-2 genome have made the virus more infectious. The model, developed by lead researcher Guowei Wei, professor in the departments of Mathematics and Biochemistry and Molecular Biology, analysed SARS-CoV-2 genotyping from more… Read More
PerkinElmer has released a series of Explorer workstations for SARS-CoV-2 testing capable of preparing and running up to 10,000 COVID-19 tests per day. These modular and scalable workstations enable laboratories to ramp up SARS-CoV-2 testing capacity quickly to generate results. Currently many laboratories are unable to deliver COVID-19… Read More
AnteoTech has developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests. These can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes. The tests use AnteoTech’s patented AnteoBind activated europium technology and provide significantly higher sensitivity than that offered by currently available COVID-19… Read More
THE COVID-19 RACE how mouse models will help researchers cross the finish line By Dr Megan MacBride The emergence of SARS-CoV-2 virus and the disease it causes, COVID-19, have fuelled significant shifts in preclinical research across the globe. Amid the worldwide health emergency created by high infection rates, rapid transmission… Read More
Chemspec Europe, which was scheduled to take place in Cologne, Germany from 11 to 12 November 2020 has been postponed. Its new dates are 19 – 20 May 2021. The exhibition will occupy Hall 12.1 at Messe Frankfurt in Germany. This decision was taken after extensive conversations with… Read More
A study early in the global coronavirus pandemic evidenced the benefits of using steroids to combat COVID-19 According to researchers at the UK’s University of Huddersfield, a study from early in the global coronavirus pandemic that evidenced the benefits of using steroids to combat COVID-19 in severely ill patients… Read More
Bold Therapeutics has released data on the novel antiviral BOLD-100. In a series of experiments conducted by Dr Stephen Barr, Associate Professor in the Department of Microbiology and Immunology at Western University, BOLD-100 and remdesivir were tested head-to-head in a cytopathic effect assay against a live Wuhan strain… Read More
By Dr Karin Bottcher High content screening (HCS) has played a significant role in infectious disease research and drug discovery to date and can be a strong tool in the age of COVID-19 and beyond. With a focus on viral diseases, this article will describe how HCS has been used… Read More
By Dr Ross Macdonald Cell-based therapies are being widely recognised for their potential to treat a variety of medical conditions, but they face major obstacles toward commercialisation. Traditionally, they have been difficult and expensive to make in large quantities. Biopharmaceutical companies must develop manufacturing solutions that will enable them to… Read More
First European Commission COVID-19 vaccine agreement enables all EU member states to access the vaccine at no profit during the pandemic. AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of the AZD1222 COVID-19 vaccine. Building on the existing agreement… Read More
George Washington University researchers analysed five biomarkers present in the blood of hundreds of COVID-19 patients, finding elevated levels associated with higher odds of clinical deterioration and death. “When we first started treating COVID-19 patients, we watched them get better or get worse, but we didn’t know why,”… Read More
UK government to purchase 60 million doses of NVX-CoV2373. Novavax, a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, has signed a deal with the UK government for the purchase of 60 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine, and a Phase 3 clinical trial… Read More
This year’s Analytica will be available in two formats – physical and digital. Organisers of the event for laboratory technology, analysis and biotechnology will also run Analytica Virtual to enable exhibitors and visitors who cannot come to Munich due to travel restrictions to participate. Analytica Virtual will run alongside… Read More
